Clin2
NCT06191965Possibly a fitRecruiting

MitoQ supplement for early psychosis

Schizophrenia and Related DisordersMitochondrial AlterationCognitive Impairment

Part of Mental health clinical trials.

This study tests whether a supplement called MitoQ can help people with early-stage psychosis by improving how their cells produce energy. If you are younger and have been treated for psychosis for less than 5 years, this trial may be an option for you.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2/Phase 3
Enrollment
100 people
Ages
18 years to 35 years
Study type
Interventional

Who can take part

  • You are between 18 and 35 years old.
  • You have been diagnosed with schizophrenia, schizoaffective disorder, or a related psychosis.
  • You have been treated for psychosis for less than 5 years.
  • You are not currently dependent on alcohol or drugs (except tobacco or mild/moderate cannabis use).
  • You have not taken antioxidant supplements (like fish oil, vitamin E, or vitamin C) in the last 14 days.
  • You are not pregnant, breastfeeding, or planning to become pregnant during the study.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06027554Recruiting· Phase 2
MitoQ for frailty, walking, memory, and blood flow in older adults

This trial tests whether a supplement called MitoQ can improve blood vessel health, walking speed, and thinking skills in older adults who are frail or have mild memory problems. It aims to see if MitoQ helps maintain independence and quality of life.

Farmington, Connecticut
NCT07393464Not yet recruiting
PQQ for cognitive and negative symptoms in schizophrenia

This trial tests if a supplement called PQQ can help with cognitive problems and negative symptoms (like lack of motivation) in people with schizophrenia. It may offer a new way to support current treatment.

NCT07229261Recruiting
MitoQ for blood vessel health in preeclampsia

This study tests whether a supplement called MitoQ can improve blood vessel function in pregnant people with preeclampsia. It may help you if you have preeclampsia and are not planning to deliver right away.

Milwaukee, Wisconsin
NCT04226898Recruiting· Phase 2
Synbiotic supplement to lessen schizophrenia symptoms

This Phase 2 trial tests whether a “synbiotic” supplement (a mix of probiotics and prebiotics) can reduce symptoms of schizophrenia or schizoaffective disorder. It may help by targeting gut-related immune and inflammation pathways that could affect brain symptoms.

Batlimore, Maryland
NCT07263022Recruiting· Phase 3
Cognitive Training for Early Psychosis Study

This study tests whether a cognitive training program can help young adults with recent psychosis improve their thinking and memory skills. It involves brain scans and cognitive exercises.

Minneapolis, Minnesota
NCT06729671Recruiting
Probiotics for antipsychotic-related metabolic issues

This trial tests if a probiotic supplement can help reduce metabolic side effects (like weight gain or high blood sugar) caused by antipsychotic medications. It is for people with psychosis who are on stable treatment.

Cork

Hear when a new Schizophrenia and Related Disorders trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.